Table 2.
Information on mechanical thrombectomy, according to the hyperglycemic patterns.
| Persistent Normoglycemia | Baseline Hyperglycemia | 24-h Hyperglycemia | Persistent Hyperglycemia | p | |
|---|---|---|---|---|---|
| (n = 116) | (n = 36) | (n = 17) | (n = 31) | ||
| Site of LVO | 0.5 | ||||
| MCA, n (%) | 80 (69.0) | 22 (61.1) | 13 (76.5) | 24 (77.4) | |
| Tandem, n (%) | 26 (22.4) | 7 (19.4) | 3 (17.6) | 5 (16.1) | |
| Vertebrobasilar, n (%) | 10 (8.6) | 7 (19.4) | 1 (5.9) | 2 (6.5) | |
| Type of device use for MT | 0.6 | ||||
| Thromboaspiration, n (%) | 42 (36.2) | 11 (30.6) | 6 (35.3) | 9 (29) | |
| Stent retriever, n (%) | 5 (4.3) | 2 (5.6) | 2 (11.8) | 3 (9.7) | |
| Thromboaspiration plus stent retriever, n (%) | 49 (42.2) | 17 (47.2) | 9 (52.9) | 12 (38.7) | |
| Permanent stenting, n (%) | 20 (17.2) | 6 (16.7) | 0 (0.0) | 7 (22.6) | |
| Other information on MT | |||||
| Secondary embolization, n (%) | 6 (5.2) | 4 (11.1) | 3 (17.6) | 3 (9.7) | 0.3 |
| Time from symptoms onset to MT, min | 210 (170–260) | 236 (205–270) | 225 (195–310) | 210 (155–255) | 0.08 |
| Procedure length, min | 67.5 (50–98.7) | 70 (50–85) | 70 (42.5–95) | 65 (40–120) | 0.9 |
| Successful recanalization rate, n (%) | 102 (87.9) | 29 (80.6) | 13 (76.5) | 26 (83.9) | 0.5 |
MT: Mechanical thrombectomy; LVO: large vessel occlusion; MCA: middle cerebral artery.